Skip to main content

Science and Technology

Image
U.S. House of Representative seal
March 1, 2023

WASHINGTON – On the first day of Cerebral Palsy Awareness Month, Congressman Steve Cohen (TN-09) today introduced the bipartisan Cerebral Palsy Research Program Authorization Act, to investigate the prevention, diagnosis, treatment and societal costs of cerebral palsy, the most prevalent life-long physical disability.

The bill is currently cosponsored by Congressmen Brian Fitzpatrick (R-PA) and Emanuel Cleaver (D-MO).

Image
U.S. House of Representative seal
February 27, 2023

WASHINGTON – Congressman Steve Cohen (TN-09) today announced that St. Jude Children’s Research Hospital will receive a grant of $708,579 to study hematopoietic stem cell dysfunction in sickle cell disease from the National Heart, Lung and Blood Institute.

Congressman Cohen made the following statement:

Image
U.S. House of Representative seal
February 27, 2023

WASHINGTON – Congressman Steve Cohen (TN-09) today announced that St. Jude Children’s Research Hospital will receive a $1,247,879 grant from the National Institute of Allergies and Infectious Diseases for research mapping the genomic and molecular mechanisms of antifungal resistance in the emerging fungal pathogen Candida auris, often spread in health care settings.

Congressman Cohen made the following statement:

Image
U.S. House of Representative seal
February 21, 2023

WASHINGTON – Congressman Steve Cohen (TN-09) today wrote to Comptroller General Gene L. Dodaro of the U.S. Government Accountability Office seeking a review of the federal government’s costs associated with treating patients who used asbestos-contaminated Johnson & Johnson baby powder and became ill because of their exposure to this known carcinogen.

The letter reads in part:

Image
U.S. House of Representative seal
February 10, 2023

MEMPHIS – Congressman Steve Cohen (TN-09) today announced that St. Jude Children’s Research Hospital will receive a $754,116 grant from the National Cancer Institute to study the cerebellar origins of medulloblastoma subgroups.

Congressman Cohen made the following statement:

Image
U.S. House of Representative seal
February 8, 2023

WASHINGTON – Congressman Steve Cohen (TN-09) today spoke from the House floor and then voted against a Republican-sponsored resolution to terminate the requirement established by the Centers for Disease Control and Prevention (CDC) for proof of COVID-19 vaccination for foreign travelers to the United States. The vote on passage of the resolution was 227 to 201.

Image
U.S. House of Representative seal
February 7, 2023

WASHINGTON – Congressman Steve Cohen (TN-09) today announced that the University of Tennessee Health Science Center (UTHSC) will receive a grant of $231,000 to study extracellular vesicles from the National Institute on Aging.

Congressman Cohen made the following statement:

Image
U.S. House of Representative seal
February 2, 2023

WASHINGTON – Congressman Steve Cohen (TN-09) today announced that the University of Tennessee Health Science Center (UTHSC) will receive $3,148,012 from the Federal Emergency Management Agency (FEMA) to reimburse expenses it incurred in ramping up to address the COVID-19 pandemic threat. The funding will pay for, among other things, the rental of tents used for testing at the center’s parking garages, protective clothing and equipment, additional oxygen supplies and freezers for storing vaccines.

Image
U.S. House of Representative seal
January 31, 2023

WASHINGTON – Congressman Steve Cohen (TN-09), recently sworn in to a ninth term, today was named the Ranking Member, or the top member of the minority Democratic Party, on the Transportation and Infrastructure (T&I) Committee’s Aviation Subcommittee, where he will oversee policy on airports, air cargo, commercial airline service and passenger safety.

Image
U.S. House of Representative seal
January 25, 2023

WASHINGTON -- Congressman Steve Cohen (TN-09) today announced a $512,103 grant to the University of Tennessee Health Science Center (UTHSC) to study the role of sensory receptors in Angelman Syndrome, a rare neurological disease affecting balance, motor impairment and seizures. The grant is from the National Institute of Neurological Disorders and Stroke.

Congressman Cohen made the following statement: